2000
DOI: 10.1016/s0168-8278(00)80277-9
|View full text |Cite
|
Sign up to set email alerts
|

Relationship between copper, zinc and metallothionein in hepatocellular carcinoma and its surrounding liver parenchyma

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

9
61
1

Year Published

2003
2003
2022
2022

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 97 publications
(71 citation statements)
references
References 20 publications
9
61
1
Order By: Relevance
“…Under these conditions, zinc plasma concentrations are normally reduced and copper levels are elevated (6). Similar observations have been reported in the liver tissue of patients with hepatocellular carcinoma (7).…”
Section: Introductionsupporting
confidence: 76%
“…Under these conditions, zinc plasma concentrations are normally reduced and copper levels are elevated (6). Similar observations have been reported in the liver tissue of patients with hepatocellular carcinoma (7).…”
Section: Introductionsupporting
confidence: 76%
“…It was found that in the presence of Cu (II) the calf thymus DNA was remarkably damaged by resveratrol and its analogues, and induced cytotoxicity in human leukemia HL-60 and Jurkat cell lines. These data were supported by Ebara et al (2000) which found that hepatocellular carcinoma have an accumulation of copper than that in the surrounding liver parenchyma. The accumulation of Cu and the present of metallothionein may be related to the carcinogenesis of HCC.…”
Section: Resultsmentioning
confidence: 57%
“…Significantly downregulated genes were identified only at the higher copper concentrations (400 and 600 M) except for Negative regulation of apoptosis (10) IGF binding (3) Protein kinase inhibitor activity (5) LDL receptor activity (2) Regulation of erythrocyte differentiation (2) Muscle cell differentiation (3) Regulation of transcription (70) Oxygen and ROS metabolism (4) Ribosome assembly (3) Regulation of nitric oxide biosynthesis (2) Transcription corepressor activity (9) Ubiquitin-protein ligase activity (9) Response to stress (19) Calcium-dependent protein binding (3) Hemopoiesis (7) Cell cycle arrest (8) Peptidoglycan metabolism (3) Cell growth (14) Ribosome assembly (2) Endosome organization and biogenesis (2) GTPase activity (13) Kinase inhibitor activity (4) LDL receptor activity (3) Protein dimerization activity (24) Small GTPase-mediated signal transduction (21) Transcription corepressor activity (9) Transcription factor activity (68) Continued alanine hydroxylase (PAH) (organic acid metabolism); fibrinogen ␣-chain (FGA), fibrinogen ␤-chain (FGB), fibrinogen ␥-chain (FGG), erythropoietin (EPO), and angiopoietin-like 1 (AN-GPTL1) (circulation, coagulation, and wound healing); haptoglobin (HP) and haptoglobin-related protein (HPR) (hemoglobin binding); ankyrin repeat domain 15 (ANKRD15), BRCA1-associated RING 1 (BARD1), and centromere protein F (CENPF) (regulation of the cell cycle); and serpin peptidase inhibitor A4 (SERPINA4), serpin peptidase inhibitor I1 (SERPINI1), and reversion-inducing cysteine-rich protein with kazal motifs (RECK) (serine -type endopeptidase inhibitor activity) (Supplemental Material, Additional Data File 2).…”
Section: Gene Expression Profilementioning
confidence: 99%
“…Patients with these diseases present hepatic copper levels at milligram/gram concentrations (61). In addition to genetic disorders of copper metabolism, other pathological conditions, including hepatic necrosis, cholestatic cirrhosis, bile duct proliferation, hepatitis, and hepatocellular carcinoma, are associated with elevated copper levels (19,20,25). Environmental exposures to elevated copper levels have been reported to be as high as 160 M in drinking water and up to 90 mM in rivers (1).…”
mentioning
confidence: 99%